Molecular Biomedicine is a peer-reviewed english-language open-access journal published by Springer in Switzerland, operating under an open-access model since 2020. The journal covers Medicine.
Authors are required to pay an article processing charge to publish in Molecular Biomedicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
biomedicine, genetics, bioinformatics, molecular biology, gene editing
At a glance
- Publisher
- Springer
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2020
ISSN
- electronic
- 2662-8651
Frequently asked questions
Is Molecular Biomedicine peer-reviewed?
Yes — Molecular Biomedicine operates a Anonymous peer review review process.
Does Molecular Biomedicine charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Molecular Biomedicine publish?
Molecular Biomedicine publishes research in Medicine.
What languages does Molecular Biomedicine accept?
Molecular Biomedicine accepts manuscripts in English.
What is the ISSN of Molecular Biomedicine?
ISSN:
2662-8651 (electronic).How do I submit a manuscript to Molecular Biomedicine?
Submit through the journal's official portal: visit submission page →